Healthcare of Ontario Pension Plan Trust Fund Raises Stake in iShares Biotechnology ETF (NASDAQ:IBB)

Posted by Samantha Reynolds on Nov 27th, 2024

Healthcare of Ontario Pension Plan Trust Fund grew its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 32.9% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 663,000 shares of the financial services provider’s stock after purchasing an additional 164,000 shares during the period. Healthcare of Ontario Pension Plan Trust Fund owned approximately 1.32% of iShares Biotechnology ETF worth $96,533,000 at the end of the most recent reporting period.

Several other institutional investors also recently made changes to their positions in IBB. Darwin Wealth Management LLC acquired a new position in shares of iShares Biotechnology ETF during the 3rd quarter worth $29,000. Highline Wealth Partners LLC acquired a new position in shares of iShares Biotechnology ETF during the 3rd quarter worth $30,000. Bbjs Financial Advisors LLC acquired a new position in shares of iShares Biotechnology ETF during the 2nd quarter worth $31,000. Ashton Thomas Securities LLC acquired a new position in shares of iShares Biotechnology ETF during the 3rd quarter worth $36,000. Finally, Voisard Asset Management Group Inc. acquired a new position in shares of iShares Biotechnology ETF during the 3rd quarter worth $59,000. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Up 0.2 %

NASDAQ:IBB opened at $140.23 on Wednesday. iShares Biotechnology ETF has a 52-week low of $117.28 and a 52-week high of $150.57. The stock has a fifty day simple moving average of $143.27 and a 200-day simple moving average of $141.92.

iShares Biotechnology ETF Dividend Announcement

The company also recently declared a dividend, which was paid on Monday, September 30th. Stockholders of record on Wednesday, September 25th were paid a dividend of $0.2005 per share. The ex-dividend date was Wednesday, September 25th.

iShares Biotechnology ETF Profile

(Free Report)

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.